Abstract
The effects were studied of the non-specific phosphodiesterase inhibitor, theophylline (37.5-300 μM), on intracellular levels of cyclic adenosine monophosphate (cAMP) and superoxide generation following exposure of human neutrophils to four different stimuli of neutrophil membrane-associated oxidative metabolism, each of which utilizes a different transductional mechanism to activate NADPH-oxidase, in vitro. Exposure of neutrophils to FMLP (1 μM), the calcium ionophore A23187 (1 μM), and opsonized zymosan (OZ, 0.5 mg/ml) was accompanied by activation of superoxide production and increased concentrations of intracellular cAMP. Inclusion of theophylline resulted in augmentation of cAMP and inhibition of superoxide production by these stimuli. These negative effects of theophylline on neutrophil superoxide generation were mimicked by dibutyryl cAMP and 8-bromo-cGMP, while the inhibitory activity of all 3 agents was antagonized by the protein kinase A inhibitor KT 5720, but not by the G-kinase inhibitor KT 5823. Unlike FMLP, OZ and A23187, intracellular cAMP levels did not increase in cells activated with phorbol-12-myristate-13-acetate (PMA, 25 ng/ml), while oxidant production activated by this stimulus was insensitive to the inhibitory effects of theophylline. These observations suggest that the beneficial, anti-inflammatory interactions of theophylline with human nuetrophils are related to the phosphodiesterase inhibitory properties of this agent, and are selective for those pro-inflammatory stimuli which elevate cAMP, resulting in enhanced activity of protein kinase A and inhibition of the production of potentially harmful reactive oxidants by these cells.
Similar content being viewed by others
REFERENCES
Weinberger, M., and L. Hendeles. 1996. Theophylline in asthma. N. Engl. J. Med. 334:1380–1388.
Barnes, P. J., and R. A. Pauwels. 1994. Theophylline in the management of asthma: time for reappraisal? Eur. Respir. J. 7:579–591.
Persson, C. G. A., and R. Pauwels. 1991. Pharmacology of anti-asthma xanthines. In: Pharmacology of Asthma (Eds. C. P. Page and P. J. Barnes), pp. 207–225. Springer-Verlag, London.
Kidney, J., M. Dominguez, P. M. Taylor, M. Rose, K. F. Chung, and P. J. Barnes. 1995. Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am. J. Respir. Crit. Care Med. 151:1907–1914.
Kraft, M., J. A. Torvik, J. B., Trudeau, S. E. Wenzel, and R. J. Martin. 1996. Theophylline: potential antiinflammatory effects in nocturnal asthma. J. Allergy Clin. Immunol. 97:1242–1246.
Sullivan, P., S. Bekir, Z. Jaffar, C. Page, P. Jeffrey, and J. Costello. 1994. Anti-inflammatory effects of low dose oral theophylline in atopic asthma. Lancet 343:1006–1008.
Ward, A. J. M., M. Mckennif, J. M. Evans, C. P. Page, and J. F. Costello. 1993. Theophylline-an immunomodulatory role in asthma? Am. Rev. Respir. Dis. 147:518–523.
Ohta, K., S. Sawamoto, M. Nakajima, S. Kubota, Y. Tanaka, T. Miyakasa, A. Nagai, K. Hirai, K. Mano, and H. Miyashita. 1996. The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis. Clin. Exp. Allergy, 26(Suppl. 2):10–15.
Spatafora, M., G. Chiappara, A. M. Merendino, D. D'Amico, V. Bellia, and G. Bonsignore. 1994. Theophylline suppresses the release of tumour necrosis factor-α by blood monocytes and alveolar macrophages. Eur. Respir. J. 7:223–228.
Dent, G., M. A. Giembycz, K. F. Rabe, B. Wolf, P. J. Barnes, and H. Magnussen. 1994. Theophylline suppresses human alveolar macrophage respiratory burst through phosphodiesterase inhibition. Am. J. Respir. Cell Mol. Biol. 10:565–572.
Nielson, C. P., J. J. Crowley, M. E. Morgan, and R. E. Vestal. 1988. Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic-3′,5′-adenosine monophosphate. Am. Rev. Respir. Dis. 137:25–30.
De Togni, P., G. Cabrini, and F. Di Virgilio. 1984. Cyclic AMP inhibition of fMet-Leu-Phedependent metabolic responses in human neutrophils is not due to its effects on cytosolic Ca2+. Clin. Exp. Immunol. 224:629–635.
Kaneko, M., K. Suzuki, H. Furui, K. Takagi, and T. Satake. 1990. Comparison of theophylline and enprofylline effects on human neutrophil superoxide production. Clin. Exp. Pharmacol. Physiol. 17:849–859.
Kato, M., A. Morikawa, H. Kimura, T. Shimizu, M. Nakano, and T. Kuroume. 1991. Effects of antiasthma drugs on superoxide anion generation from human polymorphonuclear leucocytes or hypoxanthine-xanthine oxidase system. Int. Arch. Allergy Appl. Immunology. 96:128–133.
Llewellyn-Jones, C. G., and R. A. Stockley. 1994. The effects of B2-agonists and methyl-xanthines on neutrophil function in vitro. Eur. Respir. J. 7:1460–66.
Minkenberg, I., and E. Ferber. 1984. Lucigenin-dependent chemiluminescence as a new assay for NADPH-oxidase activity in particulate fractions of human polymorphonuclear leucocytes. J. Immunol. Meth. 71:61–67.
Kase, H., K. Iwahasi, S. Nakanishi, Y. Matsuda, K. Yamada, M. Takahashi, C. Murakata, A. Sato, and M. Kaneko. 1987. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Comm. 142:436–440.
Holmsen, H. E., E. Storm, and H. J. Day. 1972. Determination of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma. Anal. Biochem. 46:481–502.
Dianzani, C., S. Brunelleschi, I. Viano, and R. Fantozzi. 1994. Adenosine modulation of primed human neutrophils. Eur. J. Pharmacol. 263:223–226.
Cronstein, B. N., S. B. Kramer, G. Weissmann, and R. Hirschhorn. 1983. Adenosine: A physiological modulator of superoxide anion generation by human neutrophils. J. Exp. Med. 158:1160–1177.
Verghese, M. W., K. Fox, L. C. McPhail, and R. Snyderman. 1985. Chemo-attractantelicited alterations of cAMP levels in human polymorphonuclear leucocytes require a Ca2+-dependent mechanism which is independent of transmembrane activation of adenylate cyclase. J. Biol. Chem. 260:6769–6775.
Schudt, C., H. Tenor, and A. Hatzelman. 1995. PDE isoenzymes as targets for anti-asthma drugs. Eur. Respir. J. 8:1179–1183.
Barnes, P. J. 1995. Cyclic nucleotides and phosphodiesterases and airway function. Eur. Respir. J. 8:457–462.
Francis, S. H., B. D. Noblett, B. W. Todd, J. Y. Wells, and J. D. Corbin. 1988. Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase. Mol. Pharmacol. 34:506–517.
Lincoln, T. M., T. L. Cornwell, and A. E. Taylor. 1990. cGMP-dependent protein kinase mediates the reduction of Ca2+ by cAMP in vascular smooth muscle cells. Am. J. Physiol. 258:C399–C407.
Lagast, H., T. Pozzan, F. A. Waldvogel, and P. D. Lew. 1984. Phorbol myristate acetate stimulates ATP-dependent calcium transport by the plasma membrane of neutrophils. J. Clin. Invest. 73:878–883.
Naccache, P. H., T. F. P. Molski, P. Borgeat, J. R. White, and R. I. Sah'afi. 1985. Phorbol esters inhibit the fmet-leu-phe and leukotriene B4-stimulated calcium mobilisation and enzyme secretion in rabbit neutrophils. J. Biol. Chem. 260:2125–2131.
Tao, J., J. S. Johansson, and D. H. Haynes. 1992. Stimulation of dense tubular Ca2+ uptake in human platelets by cAMP. Biochim. Biophys. Acta. 1105:29–39.
Johansson, J. S., L. E. Nied, and D. H. Haynes. 1992. Cyclic AMP stimulates Ca2+-ATPase-mediated Ca2+ extrusion from human platelets. Biochim. Biophys. Acta. 1105:19–28.
Johansson, J. S., and D. H. Haynes. 1992. Cyclic GMP increases the rate of the calcium extrusion pump in intact human platelets but has no direct effect on the dense tubular calcium accumulation system. Biochim. Biophys. Acta. 1105:40–50.
Hettasch, J. M., and G. C. Le Breton. 1987. Modulation of Ca2+ fluxes in isolated platelet vesicles: effects of cAMP-dependent protein kinase inhibitor on Ca2+ sequestration and release. Biochim. Biophys. Acta. 931:49–58.
Ahmed, M. U., K. Hazeki, O. Hazeki, T. Katada, and M. Ui. 1995. Cyclic AMP-increasing agents intefere with chemoattractant-induced respiratory burst in neutrophils as a result of the inhibition of phosphatidylinositol 3-kinase rather than receptor-operated Ca2+ influx. J. Biol. Chem. 270:23816–23822.
Schudt, C., S. Winder, S. Forderkunz, A. Hatzelmann, and V. Ullrich. 1991. Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai. Naunyn-Shmiedebergs Arch. Pharmacol. 344:682–690.
Villagrasa, V., C. Navarette, C. Sanz, L. Berto, M. Perpina, J. Cortijo, and E. J. Morcillo. 1996. Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes. Meth. Find. Exp. Clin. Pharmacol. 18:239–245.
Fahy, J. V., K. W. Kim, J. Liu, and H. A. Boushey. 1995. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J. Allergy. Clin. Immunol. 95:843–852.
Lamblin, C., P. Gosset, I. Tillie-Leblond, F. Saulnier, C.-H. Marquette, B. Walleart, and A. B. Tonnel. 1998. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am. J. Respir. Crit. Care Med. 157:394–402.
Zurier, R. B., G. Weissmann, S. Hoffstein, S. Kammerman, and H.-H. Tai. 1974. Mechanisms of lysozomal enzyme release from human leukocytes, II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J. Clin. Invest. 53:297–309.
Moore, A. R., and D. A. Willoughby. 1995. The role of cAMP-regulation in controlling inflammation. Clin. Exp. Immunol. 101:387–389.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mahomed, A.G., Theron, A.J., Anderson, R. et al. Anti-Oxidative Effects of Theophylline on Human Neutrophils Involve Cyclic Nucleotides and Protein Kinase A. Inflammation 22, 545–557 (1998). https://doi.org/10.1023/A:1022306328960
Issue Date:
DOI: https://doi.org/10.1023/A:1022306328960